Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development.

Gaburro S, Berridge B, Kelley NW, Keutz EV, Ferrer M, Roper C, Fossler MJ, Bajramovic JJ, Valentin JP, McGovern T, Bourcier T, Wange RL, Snyder K, Phelan MA, Oliphant JH, Leishman DJ, Proctor WR, Maguire S, Dama P, Nag M, Williams DP, Roth A, Kanda Y, Baran S

Open source

DOI: 10.1016/j.yrtph.2026.106237
Published: 2026 Sep 4
Container: Regulatory toxicology and pharmacology : RTP
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.yrtph.2026.106237,
  title = {Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development.},
  author = {Gaburro S and Berridge B and Kelley NW and Keutz EV and Ferrer M and Roper C and Fossler MJ and Bajramovic JJ and Valentin JP and McGovern T and Bourcier T and Wange RL and Snyder K and Phelan MA and Oliphant JH and Leishman DJ and Proctor WR and Maguire S and Dama P and Nag M and Williams DP and Roth A and Kanda Y and Baran S},
  year = {2026},
  journal = {Regulatory toxicology and pharmacology : RTP},
  doi = {10.1016/j.yrtph.2026.106237},
  url = {https://doi.org/10.1016/j.yrtph.2026.106237}
}

RIS

TY  - JOUR
TI  - Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development.
AU  - Gaburro S
AU  - Berridge B
AU  - Kelley NW
AU  - Keutz EV
AU  - Ferrer M
AU  - Roper C
AU  - Fossler MJ
AU  - Bajramovic JJ
AU  - Valentin JP
AU  - McGovern T
AU  - Bourcier T
AU  - Wange RL
AU  - Snyder K
AU  - Phelan MA
AU  - Oliphant JH
AU  - Leishman DJ
AU  - Proctor WR
AU  - Maguire S
AU  - Dama P
AU  - Nag M
AU  - Williams DP
AU  - Roth A
AU  - Kanda Y
AU  - Baran S
PY  - 2026
JO  - Regulatory toxicology and pharmacology : RTP
DO  - 10.1016/j.yrtph.2026.106237
UR  - https://doi.org/10.1016/j.yrtph.2026.106237
ER  -

APA

S, G., B, B., NW, K., EV, K., M, F., C, R., MJ, F., JJ, B., JP, V., T, M., T, B., RL, W., K, S., MA, P., JH, O., DJ, L., WR, P., S, M., P, D., M, N., DP, W., A, R., Y, K., & S, B. (2026). Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development.. Regulatory toxicology and pharmacology : RTP. https://doi.org/10.1016/j.yrtph.2026.106237

Source records

pubmed · retrieved 2026-09-25T10:29:11.415Z